COMMUNIQUÉS West-GlobeNewswire

TytoCare Partners with Five New Health Systems to Expand School Health Initiative to 100+ Additional Schools Nationwide
14/05/2024
Through partnerships with 73 health systems and FQHCs, TytoCare now powers clinics in more than 2,500+ schools in 31 states, ensuring students receive high-quality care without an avoidable visit to the doctor NEW YORK [...]
Merit Medical Expands Embolics Portfolio with New Siege™ Vascular Plug and Bearing nsPVA Express™ Prefilled Syringe
14/05/2024
New products broaden Merit’s leadership in embolotherapy. Full portfolio will be exhibited at the 18 th Annual GEST Meeting May 16-19 in New York City. SOUTH JORDAN, Utah, May 14, 2024 (GLOBE NEWSWIRE) -- Merit Medical [...]
Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy
14/05/2024
Placental T Cells Demonstrated Greater Persistence, Resistance to Exhaustion and Efficacy Compared To Peripheral Blood Mononuclear Cells FLORHAM PARK, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU [...]
Parity Healthcare Analytics, Maine RMOMS Network launch program to support state’s obstetrical units
14/05/2024
PORTLAND, Maine, May 14, 2024 (GLOBE NEWSWIRE) -- Parity Healthcare Analytics and the Maine Rural Maternity & Obstetrics Management Strategies Network (RMOMS) announced today they are piloting a program with the [...]
GRI Bio to Present at Alliance Global Partner’s 2024 Healthcare Company Showcase
14/05/2024
Live webcast fireside chat on Tuesday, May 21 st at 2:40 PM ET LA JOLLA, CA, May 14, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative [...]
Shuttle Pharma Provides First Quarter 2024 Corporate Update
14/05/2024
GAITHERSBURG, Md., May 14, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving [...]
Accumulus Synergy sponsorise une norme révolutionnaire de données sur la santé et fait ainsi un pas de plus vers le dossier international
14/05/2024
Accumulus Synergy, association du secteur à but non lucratif, est le principal promoteur et financeur d’une norme de données récemment publiée qui rationalise l’échange de données et contribue à un écosystème de soins [...]
Accumulus Synergy Sponsors Revolutionary Healthcare Data Standard, Advancing Towards Global Dossier
14/05/2024
Nonprofit Industry Association, Accumulus Synergy, is the primary sponsor and funder of a newly published data standard that streamlines data exchange and contributes to a more connected and patient-centered healthcare [...]
TerrAscend Announces May Conference Participation
14/05/2024
TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that its executive management team will [...]
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
14/05/2024
CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical research Companies amend existing drug discovery partnership for Evotec to lead continued development. Upon [...]
Aprea Therapeutics Reports First quarter 2024 Financial Results and Provides a Business Update
14/05/2024
U.S. FDA cleared IND for APR-1051, a highly selective and potentially best-in-class oral WEE1 inhibitor; Company plans to initiate Phase 1 ACESOT-1051 clinical trial in June 2024 First-in-class macrocyclic ATR inhibitor [...]
Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week
14/05/2024
MIAMI, FL, May 14, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, [...]
Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation
14/05/2024
Helocyte, a majority-owned subsidiary of Fortress Biotech, is developing Triplex for the prevention and treatment of cytomegalovirus in multiple transplant indications, as well as HIV Clinical trial funded by a NIAID [...]
Safety Shot Expands Operations to the Northeast
14/05/2024
The Company Will Launch in New York City, Long Island and The Hamptons Ahead of The Summer Months JUPITER, FL, May 14, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company), announced today its [...]
STRATA Skin Sciences Surpasses 100 Domestic Installations of TheraClear®X Devices as of March 31, 2024
14/05/2024
HORSHAM, Pa., May 14, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update
14/05/2024
– Company on track to commence Phase 1 human clinical study of lead product candidate, PALI-2108, for the treatment of Ulcerative Colitis (UC) before year end – Sufficient cash on hand to execute on business plan and [...]
Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments
14/05/2024
REDWOOD CITY, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting [...]
Ocugen Provides Business Update with First Quarter 2024 Financial Results
14/05/2024
Conference Call and Webcast Today at 8:30 a.m. ET All three first-in-class modifier gene therapy product candidates currently in the clinic with OCU400 Phase 3 in progress OCU400 on track to meet 2026 Biologics License [...]
Theriva™ Biologics to Participate in the A.G.P. Virtual Healthcare Conference
14/05/2024
ROCKVILLE, Md., May 14, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high [...]

Pages